Negative serology of Fasciola hepatica infection in patients with liver cancer in Peru: a preliminary report

dc.date.accessioned2018-11-30T22:50:33Z
dc.date.available2018-11-30T22:50:33Z
dc.date.created2018-11-30T22:50:33Z
dc.date.issued2018
dc.identifierhttps://hdl.handle.net/20.500.12866/4133
dc.identifierhttps://doi.org/10.1590/0037-8682-0180-2017
dc.description.abstractINTRODUCTION: The etiology of several hepatocellular carcinoma (HCC) cases remains largely unknown. Although Fasciola hepatica has been associated with liver fibrosis in Latin America, it has not yet been associated with HCC. This study aimed to determine the existence of specific IgG antibodies against F. hepatica in the serum samples of HCC patients. METHODS: In total, 13 serum samples from 13 HCC patients were screened using Fas2-ELISA. RESULTS: Fas2-ELISA demonstrated negative results in all HCC patients included in this study. CONCLUSIONS: The pre-existence of F. hepatica infection in HCC patients needs to be further investigated in epidemiological and experimental studies.
dc.languageeng
dc.publisherSociedade Brasileira de Medicina Tropical
dc.relationRevista da Sociedade Brasileira de Medicina Tropical
dc.relation1678-9849
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectPeru
dc.subjectAdult
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectYoung Adult
dc.subjectAnimals
dc.subjectAged
dc.subjectMiddle Aged
dc.subjectAntibodies, Helminth
dc.subjectEnzyme-Linked Immunosorbent Assay
dc.subjectAged, 80 and over
dc.subjectCarcinoma, Hepatocellular
dc.subjectFasciola hepatica
dc.subjectFascioliasis
dc.subjectImmunoglobulin G
dc.subjectLiver Neoplasms
dc.subjectRisk Factors
dc.titleNegative serology of Fasciola hepatica infection in patients with liver cancer in Peru: a preliminary report
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución